Skip Navigation

Receive this page by email each issue: [Sign up for eTOCs]

Contents: Volume 6, Supplement A, 1980   [Index by Author] 


Down Preface
Down List of Participants
Down Introduction
Down Microbiology
Down Chemistry, Pharmacology and Toxicology
Down Clinical Studies


[Search ALL Issues]


Front Matter (PDF) | Back Matter (PDF)

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Preface Back

Preface
J. Antimicrob. Chemother. 1980 6: iii; doi:10.1093/jac/6.suppl_A.iii [PDF] [Request Permissions]  

List of Participants Back

List of Participants
J. Antimicrob. Chemother. 1980 6: iv-ix; doi:10.1093/jac/6.suppl_A.iv [PDF] [Request Permissions]  

Introduction Back

Harold C. Neu
The place of cephalosporins in antibacterial treatment of infectious diseases
J. Antimicrob. Chemother. 1980 6: 1-11; doi:10.1093/jac/6.suppl_A.1 [Abstract] [PDF] [Request Permissions]  

Microbiology Back

M. H. Richmond
β-Lactamase stability of cefotaxime
J. Antimicrob. Chemother. 1980 6: 13-17; doi:10.1093/jac/6.suppl_A.13 [Abstract] [PDF] [Request Permissions]  

R. Labia, A. Kazmierczak, M. Guionie, and J. M. Masson
Some bacterial proteins with affinity for cefotaxime
J. Antimicrob. Chemother. 1980 6: 19-23; doi:10.1093/jac/6.suppl_A.19 [Abstract] [PDF] [Request Permissions]  

E. Schrinner, M. Limbert, L. Penasse, and A. Lutz
Antibacterial activity of cefotaxime and other newer cephalosporins (in vitro and in vivo)
J. Antimicrob. Chemother. 1980 6: 25-30; doi:10.1093/jac/6.suppl_A.25 [Abstract] [PDF] [Request Permissions]  

H. Knothe
Sensitivity testing and synergy
J. Antimicrob. Chemother. 1980 6: 31-35; doi:10.1093/jac/6.suppl_A.31 [Abstract] [PDF] [Request Permissions]  

S. Mitsuhashi, M. Inoue, and S. Masuyoshi
Antibacterial activity of cefotaxime
J. Antimicrob. Chemother. 1980 6: 37-46; doi:10.1093/jac/6.suppl_A.37 [Abstract] [PDF] [Request Permissions]  

Peter Piot, Eddy Van Dyck, Jan Colaert, and Jean-Paul Ursi
In vitro activity of cefotaxime and other cephalosporins against Neisseria gonorrhoeae
J. Antimicrob. Chemother. 1980 6: 47-50; doi:10.1093/jac/6.suppl_A.47 [Abstract] [PDF] [Request Permissions]  

J. M. Hubrechts, R. Vanhoof, R. Denolf, F. Khodjasteh, and J. P. Butzler
In vitro and in vivo activity of cefotaxime on gonococcal strains
J. Antimicrob. Chemother. 1980 6: 51-54; doi:10.1093/jac/6.suppl_A.51 [Abstract] [PDF] [Request Permissions]  

J. Klastersky, H. Gaya, S. H. Zinner, C. Bernard, J-C. Ryff, and EORTC International Antimicrobial Therapy Project Group Writing Committee
Cefotaxime and amikacin: results of in vitro and in vivo studies against Gram-negative bacteria and Staphylococcus aureus
J. Antimicrob. Chemother. 1980 6: 55-61; doi:10.1093/jac/6.suppl_A.55 [Abstract] [PDF] [Request Permissions]  

Chemistry, Pharmacology and Toxicology Back

R. Bucourt, D. Bormann, R. Heymes, and M. Perronnet
Chemistry of cefotaxime
J. Antimicrob. Chemother. 1980 6: 63-67; doi:10.1093/jac/6.suppl_A.63 [Abstract] [PDF] [Request Permissions]  

J. Chamberlain, J. D. Coombes, D. Dell, J. M. Fromson, R. J. Ings, C. M. Macdonald, and J. McEwen
Metabolism of cefotaxime in animals and man
J. Antimicrob. Chemother. 1980 6: 69-78; doi:10.1093/jac/6.suppl_A.69 [Abstract] [PDF] [Request Permissions]  

B. I. Doerr, R. Glomot, H. Kief, M. Kramer, and T. Sakaguchi
Toxicology of cefotaxime in comparison to other cephalosporins
J. Antimicrob. Chemother. 1980 6: 79-82; doi:10.1093/jac/6.suppl_A.79 [Abstract] [PDF] [Request Permissions]  

F. Esmieu, J. Guibert, H. C. Rosenkilde, I. Ho, and A. Le Go
Pharmacokinetics of cefotaxime in normal human volunteers
J. Antimicrob. Chemother. 1980 6: 83-92; doi:10.1093/jac/6.suppl_A.83 [Abstract] [PDF] [Request Permissions]  

D. S. Reeves, L. O. White, H. A. Holt, D. Bahari, M. J. Bywater, and R. P. Bax
Human metabolism of cefotaxime
J. Antimicrob. Chemother. 1980 6: 93-101; doi:10.1093/jac/6.suppl_A.93 [Abstract] [PDF] [Request Permissions]  

J. P. Fillastre, A. Leroy, G. Humbert, and M. Godin
Pharmacokinetics of cefotaxime in subjects with normal and impaired renal function
J. Antimicrob. Chemother. 1980 6: 103-111; doi:10.1093/jac/6.suppl_A.103 [Abstract] [PDF] [Request Permissions]  

H. M. von Hattingberg, W. Marget, B. H. Belohradsky, and R. Roos
Pharmacokinetics of cefotaxime in neonates and children: clinical aspects
J. Antimicrob. Chemother. 1980 6: 113-118; doi:10.1093/jac/6.suppl_A.113 [Abstract] [PDF] [Request Permissions]  

A. Karimi, K. Seeger, D. Stolke, and H. Knothe
Cefotaxime concentration in cerebrospinal fluid
J. Antimicrob. Chemother. 1980 6: 119-120; doi:10.1093/jac/6.suppl_A.119 [Abstract] [PDF] [Request Permissions]  

L. Moreau, H. Durand, and P. Biclet
Cefotaxime concentrations in ascites
J. Antimicrob. Chemother. 1980 6: 121-122; doi:10.1093/jac/6.suppl_A.121 [Abstract] [PDF] [Request Permissions]  

C. Morel, N. Monrocq, and Y. Besnard
Concentrations of cefotaxime in bronchial secretions
J. Antimicrob. Chemother. 1980 6: 123-124; doi:10.1093/jac/6.suppl_A.123 [Abstract] [PDF] [Request Permissions]  

C. J. Soussy, L. P. Deforges, J. Le Van Thoi, W. Feghali, and J. R. Duval
Cefotaxime concentration in the bile and wall of the gallbladder
J. Antimicrob. Chemother. 1980 6: 125-130; doi:10.1093/jac/6.suppl_A.125 [Abstract] [PDF] [Request Permissions]  

J. Danon
Cefotaxime concentrations in otitis media effusions
J. Antimicrob. Chemother. 1980 6: 131-132; doi:10.1093/jac/6.suppl_A.131 [Abstract] [PDF] [Request Permissions]  

H. Rosin, W. Uphaus, and J. Vent
Determination of cefotaxime concentrations in non-infected human bone
J. Antimicrob. Chemother. 1980 6: 133; doi:10.1093/jac/6.suppl_A.133 [Abstract] [PDF] [Request Permissions]  

Dimitris A. Kafetzis, Cosmas V. Lazarides, Constantinos A. Siafas, Panagiotis A. Georgakopoulos, and Constantinos J. Papadatos
Transfer of cefotaxime in human milk and from mother to foetus
J. Antimicrob. Chemother. 1980 6: 135-141; doi:10.1093/jac/6.suppl_A.135 [Abstract] [PDF] [Request Permissions]  

H. Busse, K. Seeger, and P. Wreesmann
Concentrations of cefotaxime in the anterior chamber of the eye in rabbits and humans
J. Antimicrob. Chemother. 1980 6: 143-145; doi:10.1093/jac/6.suppl_A.143 [Abstract] [PDF] [Request Permissions]  

J. Kosmidis, Ch. Stathakis, K. Mantopoulos, T. Pouriezi, B. Papathanassiou, and G. K. Daikos
Clinical pharmacology of cefotaxime including penetration into bile, sputum, bone and cerebrospinal fluid
J. Antimicrob. Chemother. 1980 6: 147-151; doi:10.1093/jac/6.suppl_A.147 [Abstract] [PDF] [Request Permissions]  

D. A. Kafetzis
Penetration of cefotaxime into empyema fluid
J. Antimicrob. Chemother. 1980 6: 153; doi:10.1093/jac/6.suppl_A.153 [PDF] [Request Permissions]  

A. W. Mondorf, P. Burk, T. Stefanescu, J. E. Scherberich, and W. Schoeppe
Effects of cefotaxime on the proximal tubules of the human kidney
J. Antimicrob. Chemother. 1980 6: 155-159; doi:10.1093/jac/6.suppl_A.155 [Abstract] [PDF] [Request Permissions]  

A. L. de Weck and C. H. Schneider
Allergic and immunological aspects of therapy with cefotaxime and other cephalosporins
J. Antimicrob. Chemother. 1980 6: 161-168; doi:10.1093/jac/6.suppl_A.161 [Abstract] [PDF] [Request Permissions]  

Clinical Studies Back

Fumio Miki and Kenzo Shiota
Cefotaxime in lower respiratory tract infections compared to cefazolin
J. Antimicrob. Chemother. 1980 6: 169-175; doi:10.1093/jac/6.suppl_A.169 [Abstract] [PDF] [Request Permissions]  

Stephen G. Jenkinson, Michael S. Briggs, and Randy D. Bryn
Cefotaxime in the treatment of pneumococcal pneumonia
J. Antimicrob. Chemother. 1980 6: 177-180; doi:10.1093/jac/6.suppl_A.177 [Abstract] [PDF] [Request Permissions]  

P. Hänninen, A. Toivanen, O. Vainio, and P. Toivanen
Cefotaxime in the treatment of lower respiratory tract infections
J. Antimicrob. Chemother. 1980 6: 181-185; doi:10.1093/jac/6.suppl_A.181 [Abstract] [PDF] [Request Permissions]  

F. P. V. Maesen, B. I. Davies, B. M. H. Drenth, and H. Elfers
Treatment of acute exacerbations of chronic bronchitis with cefotaxime: a controlled clinical trial
J. Antimicrob. Chemother. 1980 6: 187-192; doi:10.1093/jac/6.suppl_A.187 [Abstract] [PDF] [Request Permissions]  

H. Lode, B. Kemmerich, G. Gruhlke, G. Dzwillo, P. Koeppe, and I. Wagner
Cefotaxime in bronchopulmonary infections—a clinical and pharmacological study
J. Antimicrob. Chemother. 1980 6: 193-198; doi:10.1093/jac/6.suppl_A.193 [Abstract] [PDF] [Request Permissions]  

S. W. B. Newsom, Julie Matthews, and V. R. Pearce
Cefotaxime for urinary tract infections
J. Antimicrob. Chemother. 1980 6: 199-203; doi:10.1093/jac/6.suppl_A.199 [Abstract] [PDF] [Request Permissions]  

Y. Kumamoto and A. Nishio
Cefotaxime treatment of complicated urinary tract infections
J. Antimicrob. Chemother. 1980 6: 205; doi:10.1093/jac/6.suppl_A.205 [Abstract] [PDF] [Request Permissions]  

G. Ludwig and L. Knebel
Cefotaxime in urinary tract infections—comparative clinical studies with gentamicin and with cefoxitin
J. Antimicrob. Chemother. 1980 6: 207-211; doi:10.1093/jac/6.suppl_A.207 [Abstract] [PDF] [Request Permissions]  

Yukimichi Kawada, Yasuo Shimizu, and Tsuneo Nishiura
Comparative studies of cefotaxime and sulbenicillin in complicated urinary tract infections
J. Antimicrob. Chemother. 1980 6: 213-218; doi:10.1093/jac/6.suppl_A.213 [Abstract] [PDF] [Request Permissions]  

W. M. Glöckner, U. Höffler, J. Kindler, G. Peters, and H. G. Sieberth
Elimination kinetics of cefotaxime in patients with renal insufficiency requiring dialysis
J. Antimicrob. Chemother. 1980 6: 219-223; doi:10.1093/jac/6.suppl_A.219 [Abstract] [PDF] [Request Permissions]  

José Maria Casellas, Roberto Gonzalez Ortiz, Adriana Matteucci, Maria Angelica Iribarren, and Alicia Farinati
Cefotaxime therapy of urinary tract infections
J. Antimicrob. Chemother. 1980 6: 225-230; doi:10.1093/jac/6.suppl_A.225 [Abstract] [PDF] [Request Permissions]  

Mitsuo Ohkawa and Kyoichi Kuroda
A double blind clinical trial of cefotaxime and cefazolin in complicated urinary tract infections
J. Antimicrob. Chemother. 1980 6: 231-233; doi:10.1093/jac/6.suppl_A.231 [Abstract] [PDF] [Request Permissions]  

N. Lambert-Zechovsky, C. Aufrant, E. Bingen, C. Blum, M. C Proux, and H. Mathieu
Cefotaxime in children: efficacy, tolerance and effect on the intestinal bacterial flora
J. Antimicrob. Chemother. 1980 6: 235-242; doi:10.1093/jac/6.suppl_A.235 [Abstract] [PDF] [Request Permissions]  

Constantin J. Papadatos, Dimitris A. Kafetzis, and John Kanarios
Cefotaxime in the treatment of severe paediatric infections
J. Antimicrob. Chemother. 1980 6: 243-248; doi:10.1093/jac/6.suppl_A.243 [Abstract] [PDF] [Request Permissions]  

Eduardo L. López, Néstor F. Bonesana, E. Rubeglio, A. Schugurensky, G. Sommersguter, and S. Grinstein
Cefotaxime therapy in children with serious infections associated with reduced host defense mechanisms
J. Antimicrob. Chemother. 1980 6: 249-253; doi:10.1093/jac/6.suppl_A.249 [Abstract] [PDF] [Request Permissions]  

G. K. Daikos, J. Kosmidis, H. Giamarellou, B. Dranidis, Ch. Stathakis, and K. Mantopoulos
Evaluation of cefotaxime in a hospital with high antibiotic resistance rates
J. Antimicrob. Chemother. 1980 6: 255-261; doi:10.1093/jac/6.suppl_A.255 [Abstract] [PDF] [Request Permissions]  

M. Armengaud, P. Massip, J. Aubertin, J. M. Ragnaud, A. Bertrand, and G. Lepeu
Cefotaxime in the treatment of septicaemia and endocarditis
J. Antimicrob. Chemother. 1980 6: 263-268; doi:10.1093/jac/6.suppl_A.263 [Abstract] [PDF] [Request Permissions]  

Pramod M. Shah, Eilke B. Helm, and Wolfgang Stille
Management of severe systemic infections caused by multiple resistant organisms
J. Antimicrob. Chemother. 1980 6: 269-272; doi:10.1093/jac/6.suppl_A.269 [Abstract] [PDF] [Request Permissions]  

D. Regensburger, W. Konertz, and H. Oelert
Antibiotic prophylaxis in cardiac surgery
J. Antimicrob. Chemother. 1980 6: 273; doi:10.1093/jac/6.suppl_A.273 [PDF] [Request Permissions]  

J. P. Dutoy and G. Wauters
The treatment of bone and joint infections with cefotaxime
J. Antimicrob. Chemother. 1980 6: 275; doi:10.1093/jac/6.suppl_A.275 [PDF] [Request Permissions]  

M. W. McKendrick, A. M. Geddes, R. Wise, and R. Bax
Cefotaxime in septicaemia including typhoid fever
J. Antimicrob. Chemother. 1980 6: 277-281; doi:10.1093/jac/6.suppl_A.277 [Abstract] [PDF] [Request Permissions]  

J. H. Soutoul, R. Quentin, G. Boscq, Ch. Chazara, and D. Prieur
Study of cefotaxime in the treatment of obstetric and gynaecological infections
J. Antimicrob. Chemother. 1980 6: 283-285; doi:10.1093/jac/6.suppl_A.283 [Abstract] [PDF] [Request Permissions]  

M. Goulon, P. Gajdos, and P. Blondel
Treatment of five cases of septicaemia due to Gram-negative bacilli using cefotaxime alone
J. Antimicrob. Chemother. 1980 6: 287; doi:10.1093/jac/6.suppl_A.287 [PDF] [Request Permissions]  

S. Hard, I. Moberg, and K. Wennberg
Treatment of gonococcal urethritis in males with a single dose of cefotaxime
J. Antimicrob. Chemother. 1980 6: 289; doi:10.1093/jac/6.suppl_A.289 [PDF] [Request Permissions]  

A. Backhaus and J. Meyer-Rohn
The treatment of gonococcal urethritis with cefotaxime
J. Antimicrob. Chemother. 1980 6: 291; doi:10.1093/jac/6.suppl_A.291 [PDF] [Request Permissions]  

J. P. W. Young, J. M. Husson, K. Bruch, R. J. Blomer, and C. Savopoulos
The evaluation of efficacy and safety of cefotaxime: a review of 2500 cases
J. Antimicrob. Chemother. 1980 6: 293-300; doi:10.1093/jac/6.suppl_A.293 [Abstract] [PDF] [Request Permissions]  

Y. A. Chabbert
Concluding remarks
J. Antimicrob. Chemother. 1980 6: 301-302; doi:10.1093/jac/6.suppl_A.301 [PDF] [Request Permissions]  

W. Siegenthaler
Concluding remarks
J. Antimicrob. Chemother. 1980 6: 302-303; doi:10.1093/jac/6.suppl_A.302 [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.